| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,937 |
7,602 |
$1.24M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,379 |
4,830 |
$1.12M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
212 |
91 |
$165K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,677 |
1,463 |
$162K |
| 80053 |
Comprehensive metabolic panel |
3,034 |
2,474 |
$90K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,797 |
2,041 |
$79K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
817 |
705 |
$47K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,072 |
935 |
$40K |
| 87070 |
|
267 |
241 |
$31K |
| 36415 |
Collection of venous blood by venipuncture |
4,124 |
3,419 |
$29K |
| 71045 |
Radiologic examination, chest; single view |
2,483 |
2,151 |
$24K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
627 |
619 |
$18K |
| 83880 |
|
1,575 |
1,293 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
630 |
622 |
$15K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
188 |
173 |
$14K |
| 85027 |
|
6,455 |
4,936 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
742 |
711 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,268 |
945 |
$13K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
106 |
99 |
$8K |
| 81025 |
|
957 |
892 |
$6K |
| 81001 |
|
939 |
852 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,088 |
1,746 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
189 |
170 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
225 |
192 |
$5K |
| 84484 |
|
1,777 |
1,318 |
$4K |
| 81000 |
|
676 |
609 |
$4K |
| 93976 |
|
34 |
28 |
$4K |
| 81003 |
|
290 |
266 |
$4K |
| 76801 |
|
35 |
28 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
147 |
134 |
$3K |
| 85610 |
|
2,041 |
1,517 |
$3K |
| 84702 |
|
168 |
146 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
487 |
400 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
311 |
294 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
64 |
60 |
$1K |
| 83690 |
|
1,086 |
959 |
$1K |
| G0378 |
Hospital observation service, per hour |
12 |
12 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
835 |
659 |
$996.53 |
| 85730 |
|
1,360 |
1,142 |
$951.25 |
| 83735 |
|
492 |
371 |
$901.33 |
| 86900 |
|
681 |
597 |
$848.53 |
| 86901 |
|
675 |
591 |
$818.37 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
124 |
121 |
$739.54 |
| 82565 |
|
42 |
38 |
$655.43 |
| 87420 |
|
12 |
12 |
$655.04 |
| 84703 |
|
100 |
97 |
$526.29 |
| 88342 |
|
26 |
25 |
$456.37 |
| 77080 |
|
29 |
29 |
$454.02 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
191 |
169 |
$376.18 |
| 86850 |
|
61 |
49 |
$352.91 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,081 |
880 |
$290.39 |
| 87040 |
|
12 |
12 |
$238.66 |
| 72170 |
|
14 |
13 |
$200.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$190.58 |
| 83605 |
|
112 |
95 |
$186.24 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,559 |
1,271 |
$160.26 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
310 |
177 |
$90.16 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
430 |
285 |
$81.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
158 |
136 |
$46.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
74 |
65 |
$22.32 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
176 |
130 |
$17.56 |
| J7050 |
Infusion, normal saline solution, 250 cc |
62 |
47 |
$10.62 |
| 80047 |
|
13 |
13 |
$8.31 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
48 |
40 |
$2.86 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
15 |
13 |
$1.68 |
| A9270 |
Non-covered item or service |
1,330 |
619 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
73 |
62 |
$0.00 |
| J3490 |
Unclassified drugs |
32 |
26 |
$0.00 |
| 87205 |
|
13 |
12 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
230 |
210 |
$0.00 |
| 87075 |
|
13 |
12 |
$0.00 |